Clinical Trial Update: Olanzapine Versus Placebo in the Treatment of Adolescents With Schizophrenia [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update comparing olanzapine to placebo in adolescents with schizophrenia, sponsored by Eli Lilly and Company.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• olanzapine (olanzapine)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Schizophrenia | Phase 3 | Status: COMPLETED